| Literature DB >> 22781439 |
Hammed H A M Hassan1, Sabah G El-Banna, Amel F Elhusseiny, El-Sayed M E Mansour.
Abstract
We report the synthesis of aramide nanoparticles containing a chiral N-phthaloyl valine moiety and their antioxidant activities on hepatic contents of cytochrome P₄₅₀, amidopyrene N-demethylase, aniline-4-hyroxylase and induced the hepatic content of cytochrome b5 and nicotinamide adenine dinucleotide phosphate (NADPH) cytochrome C-reductase. Polymers were obtained as well-separated spherical nanoparticles while highly aggregated particles via H-bonding organization of the aramide-containing pyridine led to a thin layer formation. The effects of the nanoparticles and CCl₄ on enzyme activities and thiobarbituric acid reactive substances (TBARS) levels of male rat liver were studied. Pretreatments of rats with the polyamides prior to the administration of CCl₄ decreased the hepatic content of the tested enzymes. Doses reduced the toxic effects exerted by (•CCl₃) upon the liver through inhibition of the cytochrome P₄₅₀ system. Inhibition of such metabolizing enzymes could reduce the carcinogenic effects of chemical carcinogens.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22781439 PMCID: PMC6268142 DOI: 10.3390/molecules17078255
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Oxidation of pyridine to pyridine-N-oxide.
Scheme 2Preparation of 5-(2-phthalimidyl-3-methylbutanoylamino)-isophthaloyl chloride 6 from S-valine 3.
Scheme 3Chemical preparation of polyamide nanoparticles 9, 10 and the polyesteramide 12.
Scheme 4Chemical preparation of polyamide nanoparticles 17-20.
Physical properties of polymers 9, 10, 12 and 17–20.
| No. | Yield (%) | Unit Formula | M.Wt | % C (Exp.) | % H (Exp.) | % N (Exp.) | ηinh a | IR (KBr) (υ cm−1) | λmax (nm) |
|---|---|---|---|---|---|---|---|---|---|
| 88 | C27H24N4O6 | 500 | 64.79 (64.31) | 4.83 (4.42) | 11.19 (11.38) | 0.70 | 3464, 2968, 1768, 1712, 1608, 1549, 1488, 1450, 1386, 1334, 1248, 1115, 1071, 1017, 886, 686. | 265 300 | |
| 81 | C26H23N5O6 | 501 | 62.27 (62.63) | 4.62 (4.88) | 13.97 (13.54) | 0.62 | 3448, 1768, 1712, 1608, 1554, 1488, 1450, 1387, 1333, 1245, 1115, 1071, 1016, 999, 959, 886, 868. | 265 305 | |
| 86 | C27H23N3O7 | 501 | 64.67 (64.30) | 4.62 (4.22) | 8.38 (8.09) | 0.67 | 3423, 2966, 1769, 1713, 1656, 1605, 1548, 1494, 1451, 1385, 1354, 1335, 1255, 1174, 1157, 1117, 1077, 1016, 999, 975, 888. | 265 296 | |
| 90 | C33H28N4O6 | 576 | 68.74 (69.01) | 4.89 (4.55) | 9.72 (9.37) | 0.61 | 3457, 2967, 1769, 1713, 1652, 1597, 1523, 1502, 1467, 1447, 1415, 1385, 1331, 1116, 1070, 887. | 269 306 | |
| 84 | C33H28N4O7 | 592 | 66.88 (66.49) | 4.76 (4.41) | 9.45 (9.78) | 0.60 | 3452, 2967, 1769, 1714, 1655, 1602, 1539, 1499, 1467, 1447, 1408, 1385, 1335, 1232, 1169, 1117, 1071, 1014, 876, 832. | 268 292 | |
| 88 | C34H30N4O6 | 590 | 69.14 (70.45) | 5.12 (5.53) | 9.49 (9.81) | 0.63 | 3460, 1713, 1649, 1533, 1411, 1385, 1253, 1071, 720, 531. | 268 295 | |
| 86 | C33H28N4O8S | 640 | 61.87 (62.34) | 4.41 (4.19) | 8.75 (8.42) | 0.58 | 3468, 1770, 1714, 1674, 1593, 1529, 1447, 1394, 1320, 1252, 1148, 1106, 1071, 888, 836. | 270 305 |
a The inherent viscosity of the polymers was measured at a concentration of 0.5 g/dL in DMSO at 30 °C.
Figure 1SEM images of the aramides nanoparticles 9, 10, 12 and 17–20.
Figure 2Intramolecular hydrogen bonds in helical conformations of pyridine-containing polymers and schematic representation of double helix made by interactions of two helical monomers.
Thermoanalytical and the kinetic parameters of polymers 9, 10, 12 and 17–20.
| Cpd. No. | Stage | TG (°C) | % Wt loss | LOI a | T b |
| A (S−1) × 10−4 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| I | 200–700 | 58.60 | 320 | 6.72 | 0.47 | 1.78 | −329.1 | 199.9 | ||
| II | Residue | 41.40 | 34.1 | 425 | 22.34 | 0.72 | 16.53 | −327.0 | 244.7 | |
| 525 | 86.16 | 1.40 | 79.52 | −322.3 | 336.6 | |||||
| I | 200–700 | 58.19 | 34.2 | 425 | 19.62 | 1.97 | 17.04 | −317.2 | 184.9 | |
| II | Residue | 41.81 | ||||||||
| I | 200–700 | 58.63 | 41.1 | 320 | 82.97 | 3.72 | 78.20 | −311.8 | 256.8 | |
| II | Residue | 41.37 | ||||||||
| I | 200–700 | 68.00 | 30.3 | 200 | 74.79 | 5.18 | 70.85 | −317.7 | 221.1 | |
| II | Residue | 32.00 | 320 | 182.96 | 1.49 | 178.02 | −309.0 | 361.6 | ||
| 425 | 49.09 | 3.11 | 43.28 | −314.9 | 263.1 | |||||
| I | 200–700 | 46.82 | 38.8 | 200 | 143.60 | 1.81 | 139.66 | −316.1 | 289.2 | |
| II | Residue | 53.18 | 425 | 90.69 | 3.53 | 84.88 | −313.7 | 303.8 | ||
| I | 200–700 | 40.98 | 41.1 | 200 | 52.34 | 1.44 | 48.40 | −322.3 | 200.8 | |
| II | Residue | 59.02 | 425 | 42.50 | 2.05 | 36.74 | −318.3 | 257.3 | ||
| I | 200–700 | 52.29 | 36.6 | 425 | 133.87 | 8.40 | 128.06 | −310.8 | 345.0 | |
| II | Residue | 47.71 |
Limiting oxygen index; The peak temperature from the DTG charts; Values are in kj/mole.
Figure 3Effect of polyamides and carbon tetrachloride on drug metabolizing enzyme activities, and TBARS levels of male rat liver.